Background: Patients with persistent medically unexplained symptoms often exhibit general dysfunction and psychiatric comorbidity and frequently resist psychiatric referral. The aim of this study was to evaluate the efficacy of a collaborative care model including training for general practitioners (GPs) and a psychiatric consultation model for patients with persistent medically unexplained symptoms in general practice. Method: Randomised controlled trial. Cluster randomisation at GP practices and multilevel analysis were performed. A total of 81 patients from 36 general practices completed the study. A collaborative care model of training and psychiatric consultation in general practice in the presence of the GP was compared with training plus care as usual by the GP. Outcome assessment on the patients’ well-being, functioning and utilisation of health care services was performed 6 weeks and 6 months later. Results: All the patients had somatoform disorders (Whitely Index 7.46), and 86% had comorbid psychiatric disorders. In the intervention group, the severity of the main medically unexplained symptoms decreased by 58%. The patients’ social functioning improved. The utilization of health care was lower than in the care as usual group. Conclusions: A collaborative care model combining training with psychiatric consultation in the general practice setting is an effective intervention in the treatment of persistent medically unexplained symptoms. Anxiety and depressive disorders are highly comorbid in this group. The findings warrant a larger study.

Keywords:
General practice care, Medically unexplained symptoms, Collaborative care, Psychiatric consultation, Somatoform disorder
1.
Verhaak PF, Tijhuis MA: The somatising patient in general practice. Int J Psychiatr Med 1994;24:157–177.
2.
Von Korff M, Ormel J, Katon W, Lin EH: Disability and depression among high utilizers of health care. A longitudinal analysis. Arch Gen Psychiatry 1992;49:91–100.
3.
Speckens AE, Van Hemert AM, Spinhoven P, Hawton K, Bolk JH, Rooijmans HG: Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial. BMJ 1995;311:1328–1332.
4.
Kroenke K, Swindle R: Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000;69:205–215.
5.
Sartorius N: Psychosomatic medicine and primary health care (PHC). Psychother Psychosom 1989;52:1–3:5–9.
6.
Fava GA, Sonino N: Psychosomatic medicine: emerging trends and perspectives. Psychother Psychosom 2000;69:184–197.
7.
Mathers NJ, Gask L: Surviving the ‘heartsink’ experience. Fam Pract 1995;12:176–183.
8.
Blankenstein AH, Van der Horst HE, Schilte AF, de Vries D, Zaat JOM, Knottnerus JA, van Eijk JTM, de Haan M: Development and feasibility of a modified reattribution model for somatising patients, applied by their own general practitioners. Patient Educ Couns 2002;47:229–235.
9.
King M, Davidson O, Taylor F, Haines A, Sharp D, Turner R: Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial. BMJ 2002;324:947–950.
10.
Yeung A, Kung WW, Chung H, Rubenstein G, Roffi P, Mischoulon D, Fava M: Integrating psychiatry and primary care improves acceptability to mental health services among Chinese Americans. Gen Hosp Psychiatry 2004;4:256–260.
11.
Berardi D, Menchetti M, Dragani A, Fava C, Leggieri G, Ferrari G: The Bologna Primary Care Liaison Service: first year evaluation. Community Ment Health J 2002;38:439–445.
12.
Katon, W, Von Korff M, Lin EH, Bush T, Russo J, Lipscomb P, Wagner E: A randomized trial of psychiatric consultation with distressed high utilizers. Gen Hosp Psychiatry 1992;14:86–98.
13.
Smith GR Jr, Monson RA, Ray DC: Psychiatric consultation in somatisation disorder. A randomized controlled study. N Engl J Med 1986;314:1407–1413.
14.
Goldberg D, Gask L, O’Dowd T: The treatment of somatization: teaching techniques of reattribution. J Psychosom Res 1989;33:689–695.
15.
Gask L, Goldberg D, Porter R, Creed F: The treatment of somatization: evaluation of a teaching package with general practice trainees. J Psychosom Res 1989;33:697–703.
16.
Sartorius N, Kaelber CT, Cooper JE, Roper MT, Rae DS, Gulbinat W, Ustun TB, Regier DA: Progress toward achieving a common language in psychiatry. Results from the field trial of the clinical guidelines accompanying the WHO classification of mental and behavioral disorders in ICD-10. Arch Gen Psychiatry 1993;50:115–124.
17.
Fink P, Ewald H, Jensen J, Sorensen L, Engberg M, Holm M, Munk-Jorgensen P: Screening for somatisation and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatisation. J Psychosom Res 1999;46:261–273.
18.
Reiser MF: Implications of a biopsychosocial model for research in psychiatry. Psychosom Med 1980;42(1 suppl):141–151.
19.
Van der Feltz-Cornelis CM, Wijkel D, Verhaak PFM, Collijn DH, Huyse FJ, Van Dyck R: Psychiatric consultation for somatizing patients in the family practice setting: a feasibility study. Int J Psychiatry Med 1996;26:223–239.
20.
Goldberg D, Gask L, O’Dowd T: The treatment of somatization: teaching techniques of reattribution. J Psychosom Res 1989;33:689–695.
21.
Van der Feltz-Cornelis CM, Adèr H: Randomization in psychiatric intervention research in the general practice setting. Int J Methods Psychiatr Res 2000;9:134–142.
22.
Meeuwesen L, Arrindell WA, Huyse FJ: Psychometric qualities of the SCL-90 in outpatients with abdominal or low-back pain). Tijdsch Soc Gez 1992;70:123–131.
23.
Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS: The Sickness Impact Profile: validation of a health status measure. Med Care 1976;14:57–67.
24.
Jacobs HM, Luttik A, Touw-Otten FW, De Melker RA: The Sickness Impact Profile: results of a validation study of the Dutch version (Dutch). Ned Tijdschr Geneeskd 1990;134:1950–1954.
25.
Jacobs HM, Luttik A, Touw-Otten FW, Kastein M, De Melker RA: Measuring impact of sickness in patients with non-specific abdominal complaints in a Dutch family practice setting. Med Care 1992;30:244–251.
26.
Jacobs HM, Touw-Otten FW, De Melker RA: The evaluation of changes in functional health status in patients with abdominal complaints. J Clin Epidemiol 1996;49:163–171.
27.
Koopmans GT, Meeuwesen L, Huyse FJ, Meiland FJ, Donker JM: Effects of psychiatric consultation on medical consumption in medical outpatients with abdominal pain. Psychosomatics 1995;36:387–399.
28.
Cochran WG: Sampling Techniques, ed 3. New York, Wiley, 1977.
29.
Snijders T, Bosker R: Multilevel Analysis. An Introduction to Basic and Advanced Multilevel Modeling. London, Sage Publications, 1999.
30.
Kerry SM, Bland JM: Analysis of a trial randomised in clusters. BMJ 1998;316:54.
31.
Cohen J: Statistical Power Analysis for the Behavioural Science, ed 2. Hillsdale, Lawrence Erlbaum, 1988.
32.
Hedges L, Olkin I: Statistical Methods for Meta-Analysis. Orlando, Academic Press, 1985.
33.
Lipsey MW, Wilson DB: The efficacy of psychological, educational and behavioral treatment. Am Psychol 1993;48:1181–1209.
34.
Pilowsky I: Dimensions of hypochondriasis. Br J Psychiatry 1967;113:89–93.
35.
Reid S, Wessely S, Crayford T, Hotopf M: Frequent attenders with medically unexplained symptoms: service use and costs in secondary care. Br J Psychiatry 2002;180:248–253.
36.
Katon W, Von Korff M, Lin EH, Lipscomb P, Russo J, Wagner E, Polk E: Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990;12:355–362.
37.
Smith GR Jr, Monson RA, Ray DC: Patients with multiple unexplained symptoms. Their characteristics, functional health, and health care utilization. Arch Intern Med 1986;146:69–72.
38.
Berardi D, Menchetti M, Cevenini N, Scaini S, Versari M, De Ronchi D: Comparison between primary-care physician and ICD-10 diagnosis of depression. Psychother Psychosom 2005;74:225–230.
39.
Barrett JE, Barrett JA, Oxman TE, Gerber PD: The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 1988;45:1100–1106.
40.
Gerber PD, Barrett J, Barrett J, Manheimer E, Whiting R, Smith R. Recognition of depression by internists in primary care: a comparison of internist and ‘gold standard’ psychiatric assessments. J Gen Intern Med 1989;4:7–13.
41.
Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ: Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 1993;150:734–741.
42.
Smith RC, Korban E, Kanj M, Haddad R, Lyles JS, Lein C, Gardiner JC, Hodges A, Dwamena FC, Coffey J, Collins C: A method for rating charts to identify and classify patients with medically unexplained symptoms. Psychother Psychosom 2004;73:36–42.
43.
Boudreau DM, Capoccia KL, Sullivan SD, Blough DK, Ellsworth AJ, Clark DL, Katon WJ, Walker EA, Stevens NG: Collaborative care model to improve outcomes in major depression. Ann Pharmacother 2002;36:585–591.
44.
Katon W, Russo J, Von Korff M, Lin E, Simon G, Bush T, Ludman E, Walker E: Long-term effects of a collaborative care intervention in persistently depressed primary care patients. J Gen Intern Med 2002;17:741–748.
45.
Fava GA, Ruini C, Sonino N: Management of recurrent depression in primary care. Psychother Psychosom 2003;72:3–9.
46.
Mathers NJ, Gask L: Surviving the ‘heartsink’ experience. Fam Pract 1995;12:176–183.
47.
Gask L, Goldberg D, Porter R, Creed F: The treatment of somatization: evaluation of a teaching package with general practice trainees. J Psychosom Res 1989;33:6:697–703.
48.
Smith, GR Jr, Rost K, Kashner TM: A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatising patients. Arch Gen Psychiatry 1995;52:238–243.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.